Search - tctmd.com

Displaying 81 - 100 of 1179

Sort: Relevancy | Date

Presentation TCT 2020

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

Presenter: Dean Kereiakes

October 17, 2020

Presentation TCT 2020

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Presenter: Robert Byrne

October 17, 2020

Presentation TCT 2020

HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes

Presenter: Hyo-Soo Kim

October 17, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

News Daily News

Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document

Yael L. Maxwell

September 10, 2020

News Featured Fellow

Anum Minhas, MD

Yael L. Maxwell

August 07, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Daily News

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Michael O'Riordan

April 29, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for April

Todd Neale

April 01, 2020

News Daily News

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

Yael L. Maxwell

March 13, 2020

News Opinion Fellow Talk

A Program for Every Fellow: Maximizing Your Conference Experience as a Trainee

Luai Tabaza, MD

March 11, 2020

News Daily News

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

Todd Neale

March 09, 2020

News Opinion Off Script

COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose?

Asif Qasim, MB BChir, PhD

March 06, 2020

News Conference News ISC 2020

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

Todd Neale

February 29, 2020

News Daily News

Gender Gaps Persist in CV Research, Editorships, and Training

Yael L. Maxwell

February 20, 2020

Advertisement

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document

Anum Minhas, MD

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Remdesivir Study for COVID-19 Yields Positive Top-line Results

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

COVID-19: TCTMD’s Daily Dispatch for April

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

A Program for Every Fellow: Maximizing Your Conference Experience as a Trainee

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose?

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

Gender Gaps Persist in CV Research, Editorships, and Training

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content